medmix AG
medmix AG (MEDX.SW) Stock Competitors & Peer Comparison
See (MEDX.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDX.SW | CHF 8.75 | +1.04% | 351M | 57.53 | CHF 0.15 | +5.79% |
| GE.SW | CHF 152.00 | +4.11% | 164.8B | 48.56 | CHF 3.13 | +0.55% |
| SCHP.SW | CHF 261.80 | +1.00% | 27.8B | 27.53 | CHF 9.46 | +2.61% |
| SCHN.SW | CHF 250.00 | +0.81% | 26.6B | 26.29 | CHF 9.47 | +2.61% |
| VACN.SW | CHF 489.40 | +3.95% | 14.5B | 67.57 | CHF 7.16 | +1.29% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +2.08% |
| SUN.SW | CHF 168.00 | +3.83% | 5.6B | 19.18 | CHF 8.58 | +2.58% |
| KGX.SW | CHF 40.72 | -1.64% | 5.3B | 21.43 | CHF 1.90 | +1.84% |
| JUNGH.SW | CHF 30.90 | +0.00% | 3.5B | 11.61 | CHF 2.66 | +3.09% |
| BUCN.SW | CHF 351.50 | +2.18% | 3.4B | 14.97 | CHF 23.22 | +3.17% |
Stock Comparison
MEDX.SW vs GE.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, GE.SW has a market cap of 164.8B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while GE.SW trades at CHF 152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas GE.SW's P/E ratio is 48.56. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to GE.SW's ROE of +0.46%. Regarding short-term risk, MEDX.SW is less volatile compared to GE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check GE.SW's competition here
MEDX.SW vs SCHP.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, SCHP.SW has a market cap of 27.8B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while SCHP.SW trades at CHF 261.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas SCHP.SW's P/E ratio is 27.53. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to SCHP.SW's ROE of +0.21%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHP.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHP.SW's competition here
MEDX.SW vs SCHN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, SCHN.SW has a market cap of 26.6B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while SCHN.SW trades at CHF 250.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas SCHN.SW's P/E ratio is 26.29. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to SCHN.SW's ROE of +0.21%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHN.SW's competition here
MEDX.SW vs VACN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, VACN.SW has a market cap of 14.5B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while VACN.SW trades at CHF 489.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas VACN.SW's P/E ratio is 67.57. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to VACN.SW's ROE of +0.29%. Regarding short-term risk, MEDX.SW is less volatile compared to VACN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check VACN.SW's competition here
MEDX.SW vs RAA.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to RAA.SW's ROE of +0.29%. Regarding short-term risk, MEDX.SW is more volatile compared to RAA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check RAA.SW's competition here
MEDX.SW vs SUN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, SUN.SW has a market cap of 5.6B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while SUN.SW trades at CHF 168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas SUN.SW's P/E ratio is 19.18. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to SUN.SW's ROE of +0.24%. Regarding short-term risk, MEDX.SW is more volatile compared to SUN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SUN.SW's competition here
MEDX.SW vs KGX.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, KGX.SW has a market cap of 5.3B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while KGX.SW trades at CHF 40.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas KGX.SW's P/E ratio is 21.43. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to KGX.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is more volatile compared to KGX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check KGX.SW's competition here
MEDX.SW vs JUNGH.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to JUNGH.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to JUNGH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check JUNGH.SW's competition here
MEDX.SW vs BUCN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, BUCN.SW has a market cap of 3.4B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while BUCN.SW trades at CHF 351.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas BUCN.SW's P/E ratio is 14.97. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to BUCN.SW's ROE of +0.09%. Regarding short-term risk, MEDX.SW is more volatile compared to BUCN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BUCN.SW's competition here
MEDX.SW vs KU2.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, Volatility data is not available for a full comparison. MEDX.SW has daily volatility of 1.82 and KU2.SW has daily volatility of N/A.Check KU2.SW's competition here
MEDX.SW vs GF.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, GF.SW has a market cap of 3.3B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while GF.SW trades at CHF 41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas GF.SW's P/E ratio is 16.90. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to GF.SW's ROE of +1.22%. Regarding short-term risk, MEDX.SW is more volatile compared to GF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check GF.SW's competition here
MEDX.SW vs WAF.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, WAF.SW has a market cap of 2.2B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while WAF.SW trades at CHF 71.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas WAF.SW's P/E ratio is 6.86. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to WAF.SW's ROE of -0.04%. Regarding short-term risk, MEDX.SW is more volatile compared to WAF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check WAF.SW's competition here
MEDX.SW vs KARN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, KARN.SW has a market cap of 1.8B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while KARN.SW trades at CHF 244.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas KARN.SW's P/E ratio is 47.48. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to KARN.SW's ROE of +0.16%. Regarding short-term risk, MEDX.SW is less volatile compared to KARN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check KARN.SW's competition here
MEDX.SW vs BCHN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, BCHN.SW has a market cap of 1.6B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while BCHN.SW trades at CHF 485.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas BCHN.SW's P/E ratio is 15.18. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to BCHN.SW's ROE of +0.36%. Regarding short-term risk, MEDX.SW is more volatile compared to BCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BCHN.SW's competition here
MEDX.SW vs INRN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, INRN.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while INRN.SW trades at CHF 1,512.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas INRN.SW's P/E ratio is 21.85. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to INRN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is less volatile compared to INRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check INRN.SW's competition here
MEDX.SW vs BLD.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to BLD.SW's ROE of -0.15%. Regarding short-term risk, MEDX.SW is more volatile compared to BLD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BLD.SW's competition here
MEDX.SW vs OERL.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, OERL.SW has a market cap of 1B. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while OERL.SW trades at CHF 3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas OERL.SW's P/E ratio is -19.41. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to OERL.SW's ROE of -0.02%. Regarding short-term risk, MEDX.SW is less volatile compared to OERL.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check OERL.SW's competition here
MEDX.SW vs BYS.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, BYS.SW has a market cap of 431.4M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while BYS.SW trades at CHF 212.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas BYS.SW's P/E ratio is -14.93. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to BYS.SW's ROE of -0.05%. Regarding short-term risk, MEDX.SW is less volatile compared to BYS.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check BYS.SW's competition here
MEDX.SW vs PM.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas PM.SW's P/E ratio is 10.47. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to PM.SW's ROE of +0.09%. Regarding short-term risk, MEDX.SW is more volatile compared to PM.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PM.SW's competition here
MEDX.SW vs PMN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, PMN.SW has a market cap of 386.1M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while PMN.SW trades at CHF 410.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas PMN.SW's P/E ratio is 13.65. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to PMN.SW's ROE of +0.09%. Regarding short-term risk, MEDX.SW is more volatile compared to PMN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PMN.SW's competition here
MEDX.SW vs MTG.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, MTG.SW has a market cap of 379.5M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while MTG.SW trades at CHF 35.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas MTG.SW's P/E ratio is 25.11. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to MTG.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to MTG.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check MTG.SW's competition here
MEDX.SW vs NOEJ.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, NOEJ.SW has a market cap of 367.1M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while NOEJ.SW trades at CHF 73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas NOEJ.SW's P/E ratio is 43.89. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to NOEJ.SW's ROE of -0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to NOEJ.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check NOEJ.SW's competition here
MEDX.SW vs MIKN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, MIKN.SW has a market cap of 279.7M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while MIKN.SW trades at CHF 16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas MIKN.SW's P/E ratio is 8.59. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to MIKN.SW's ROE of +0.14%. Regarding short-term risk, MEDX.SW is less volatile compared to MIKN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check MIKN.SW's competition here
MEDX.SW vs KOMN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, KOMN.SW has a market cap of 257.3M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while KOMN.SW trades at CHF 50.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas KOMN.SW's P/E ratio is -28.36. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to KOMN.SW's ROE of -0.02%. Regarding short-term risk, MEDX.SW is less volatile compared to KOMN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check KOMN.SW's competition here
MEDX.SW vs STGN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, STGN.SW has a market cap of 186.3M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while STGN.SW trades at CHF 33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas STGN.SW's P/E ratio is 34.80. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to STGN.SW's ROE of +0.02%. Regarding short-term risk, MEDX.SW is less volatile compared to STGN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check STGN.SW's competition here
MEDX.SW vs FTON.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, FTON.SW has a market cap of 131M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while FTON.SW trades at CHF 9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas FTON.SW's P/E ratio is -16.48. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to FTON.SW's ROE of -0.02%. Regarding short-term risk, MEDX.SW is less volatile compared to FTON.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check FTON.SW's competition here
MEDX.SW vs RIEN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, RIEN.SW has a market cap of 116M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while RIEN.SW trades at CHF 3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas RIEN.SW's P/E ratio is -2.40. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to RIEN.SW's ROE of -0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to RIEN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check RIEN.SW's competition here
MEDX.SW vs TOHN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to TOHN.SW's ROE of +0.02%. Regarding short-term risk, MEDX.SW is less volatile compared to TOHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check TOHN.SW's competition here
MEDX.SW vs KLIN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, KLIN.SW has a market cap of 92.8M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while KLIN.SW trades at CHF 10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas KLIN.SW's P/E ratio is -35.00. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to KLIN.SW's ROE of -0.02%. Regarding short-term risk, MEDX.SW is more volatile compared to KLIN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check KLIN.SW's competition here
MEDX.SW vs STRN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, STRN.SW has a market cap of 20.8M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while STRN.SW trades at CHF 18.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas STRN.SW's P/E ratio is -28.92. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to STRN.SW's ROE of -0.04%. Regarding short-term risk, MEDX.SW is more volatile compared to STRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check STRN.SW's competition here
MEDX.SW vs PEDU.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, PEDU.SW has a market cap of 5.6M. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while PEDU.SW trades at CHF 47.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas PEDU.SW's P/E ratio is -5.29. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to PEDU.SW's ROE of -0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to PEDU.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PEDU.SW's competition here
MEDX.SW vs BOBNN.SW Comparison April 2026
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 351M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, MEDX.SW is priced at CHF 8.75, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 57.53, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, MEDX.SW's ROE is +0.02%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, MEDX.SW is less volatile compared to BOBNN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check BOBNN.SW's competition here